Literature DB >> 20123164

Persistence with statins and incident cataract: a population-based historical cohort study.

Gabriel Chodick1, Anthony D Heymann, Shira Flash, Ehud Kokia, Varda Shalev.   

Abstract

PURPOSE: In recent years, there is a growing body of evidence suggesting that statins may have anti-inflammatory effects; consequently, it was hypothesized that statins may have a preventive effect against cataract.
METHODS: The study was carried out on a retrospective cohort of 180,291 new statin users in a large health organization in Israel. Study participants were followed between 1998 and 2007 for incident cataract or cataract extraction.
RESULTS: During the study period 27,301 cataracts were diagnosed and 6,976 cataract extractions were performed among study participants. Persistence with statins was associated significantly (P < 0.001) with a reduced risk of cataract in men and women aged 45 to 74. Men aged 45-54 with a high (>80%) proportion of follow-up days covered with statins had an adjusted hazard ratio of 0.62 (95% confidence interval: 0.54-0.72), compared with patients with low persistence with statins. In elderly patients, no relationship or a positive relationship was observed.
CONCLUSIONS: Persistent statin use was significantly protective for the incidence of cataract in men and women under 75 years of age. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20123164     DOI: 10.1016/j.annepidem.2009.10.007

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  13 in total

1.  Dynamics of long-term statin therapy.

Authors:  Maarit Jaana Korhonen; Arja Helin-Salmivaara; Risto Huupponen
Journal:  Eur J Clin Pharmacol       Date:  2011-03-16       Impact factor: 2.953

2.  Statin use and the risk of Clostridium difficile in academic medical centres.

Authors:  Christine Anne Motzkus-Feagans; Amy Pakyz; Ronald Polk; Giovanni Gambassi; Kate L Lapane
Journal:  Gut       Date:  2012-03-22       Impact factor: 23.059

3.  The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.

Authors:  Shaza N Al-Holou; William R Tucker; Elvira Agrón; Traci E Clemons; Catherine Cukras; Frederick L Ferris; Emily Y Chew
Journal:  Ophthalmology       Date:  2015-10-04       Impact factor: 12.079

Review 4.  Eye on statins: A comprehensive review.

Authors:  Evan A Olson; Dean P Hainsworth; Geetha Davis; John C Hagan
Journal:  Mo Med       Date:  2013 Jul-Aug

5.  Cataract and ovarian carcinoma: is the vitamin D hypothesis alive?

Authors:  Galina Lurie; Rayna K Matsuno; Lynne R Wilkens; Pamela J Thompson; Nicholas J Ollberding; Michael E Carney; Marc T Goodman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-05       Impact factor: 4.254

Review 6.  Statins for children with familial hypercholesterolemia.

Authors:  Alpo Vuorio; Jaana Kuoppala; Petri T Kovanen; Steve E Humphries; Serena Tonstad; Albert Wiegman; Euridiki Drogari; Uma Ramaswami
Journal:  Cochrane Database Syst Rev       Date:  2017-07-07

7.  Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study.

Authors:  Gabriel Chodick; Howard Amital; Yoav Shalem; Ehud Kokia; Anthony D Heymann; Avi Porath; Varda Shalev
Journal:  PLoS Med       Date:  2010-09-07       Impact factor: 11.069

8.  Statin use and cataract surgery: a nationwide retrospective cohort study in elderly ethnic Chinese patients.

Authors:  Chao-Lun Lai; Wen-Yi Shau; Chia-Hsuin Chang; Ming-Fong Chen; Mei-Shu Lai
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

9.  Association between metabolic syndrome and age-related cataract.

Authors:  Sangshin Park; Eun-Hee Lee
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

10.  Statin Use and Incident Cataract Surgery: A Case-Control Study.

Authors:  Jay C Erie; Matthew R Pueringer; Scott M Brue; Alanna M Chamberlain; David O Hodge
Journal:  Ophthalmic Epidemiol       Date:  2016-01-14       Impact factor: 1.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.